# Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy

> **NCT04813380** · PHASE3 · COMPLETED · sponsor: **Zagazig University** · enrollment: 64 (actual)

## Conditions studied

- Effects of Immunotherapy

## Interventions

- **OTHER:** Sublingual immunotherapy

## Key facts

- **NCT ID:** NCT04813380
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-27
- **Primary completion:** 2022-09-10
- **Final completion:** 2022-10-10
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04813380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04813380, "Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04813380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*